ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank43
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-6.91%
2024228540.00%
2023-97.72%
2022-75.14%
202140.58%
2020343.53%
2019-8.87%
20180.00%